Literature DB >> 16909019

Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis.

Mariana Pehar1, Marcelo R Vargas, Patricia Cassina, Ana G Barbeito, Joseph S Beckman, Luis Barbeito.   

Abstract

Neurons and surrounding glial cells compose a highly specialized functional unit. In amyotrophic lateral sclerosis (ALS) astrocytes interact with motor neurons in a complex manner to modulate neuronal survival. Experiments using chimeric mice expressing ALS-linked mutations to Cu,Zn superoxide dismutase (SOD-1) suggest a critical modulation exerted by neighboring non-neuronal cell types on disease phenotype. When perturbed by primary neuronal damage, e.g. expression of SOD-1 mutations, neurons can signal astrocytes to proliferate and become reactive. Fibroblast growth factor-1 (FGF-1) can be released by motor neurons in response to damage to induce astrocyte activation by signaling through the receptor FGFR1. FGF-1 stimulates nerve growth factor (NGF) expression and secretion, as well as activity of the nuclear factor erythroid 2-related factor 2 (Nrf2) transcription factor. Nrf2 leads to the expression of antioxidant and cytoprotective enzymes such as heme oxygenase-1 and a group of enzymes involved in glutathione metabolism that prevent motor neuron degeneration. However, prolonged stimulation with FGF-1 or SOD-mediated oxidative stress in astrocytes may disrupt the normal neuron-glia interactions and lead to progressive neuronal degeneration. The re-expression of p75 neurotrophin receptor and neuronal NOS in motor neurons in parallel with increased NGF secretion by reactive astrocytes may be a mechanism to eliminate critically damaged neurons. Consequently, astrocyte activation in ALS may have a complex pathogenic role.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16909019     DOI: 10.1159/000089619

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  23 in total

Review 1.  The astrocyte odyssey.

Authors:  Doris D Wang; Angélique Bordey
Journal:  Prog Neurobiol       Date:  2008-10-01       Impact factor: 11.685

Review 2.  Targeted activation of astrocytes: a potential neuroprotective strategy.

Authors:  Carole Escartin; Gilles Bonvento
Journal:  Mol Neurobiol       Date:  2008-10-18       Impact factor: 5.590

Review 3.  Inflammation in ALS and SMA: sorting out the good from the evil.

Authors:  Dimitra Papadimitriou; Virginia Le Verche; Arnaud Jacquier; Burcin Ikiz; Serge Przedborski; Diane B Re
Journal:  Neurobiol Dis       Date:  2009-10-13       Impact factor: 5.996

4.  CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis.

Authors:  Maria Chiara Trolese; Alessandro Mariani; Mineko Terao; Massimiliano de Paola; Paola Fabbrizio; Francesca Sironi; Mami Kurosaki; Silvia Bonanno; Silvia Marcuzzo; Pia Bernasconi; Francesca Trojsi; Eleonora Aronica; Caterina Bendotti; Giovanni Nardo
Journal:  EBioMedicine       Date:  2020-11-09       Impact factor: 8.143

Review 5.  Redox-based therapeutics in neurodegenerative disease.

Authors:  G J McBean; M G López; F K Wallner
Journal:  Br J Pharmacol       Date:  2016-08-25       Impact factor: 8.739

6.  Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition.

Authors:  Marcus J Calkins; Marcelo R Vargas; Delinda A Johnson; Jeffrey A Johnson
Journal:  Toxicol Sci       Date:  2010-03-08       Impact factor: 4.849

Review 7.  Neurodegenerative diseases: model organisms, pathology and autophagy.

Authors:  S N Suresh; Vijaya Verma; Shruthi Sateesh; James P Clement; Ravi Manjithaya
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

8.  Ischemic neurons activate astrocytes to disrupt endothelial barrier via increasing VEGF expression.

Authors:  Ying-Na Li; Rong Pan; Xu-Jun Qin; Wei-Lin Yang; Zhifeng Qi; Wenlan Liu; Ke Jian Liu
Journal:  J Neurochem       Date:  2013-12-06       Impact factor: 5.372

9.  (-)-Epicatechin, a Natural Flavonoid Compound, Protects Astrocytes Against Hemoglobin Toxicity via Nrf2 and AP-1 Signaling Pathways.

Authors:  Xi Lan; Xiaoning Han; Qian Li; Jian Wang
Journal:  Mol Neurobiol       Date:  2016-11-18       Impact factor: 5.590

10.  Prostaglandin E2 released from activated microglia enhances astrocyte proliferation in vitro.

Authors:  Dan Zhang; Xiaoming Hu; Li Qian; Belinda Wilson; Christopher Lee; Patrick Flood; Robert Langenbach; Jau-Shyong Hong
Journal:  Toxicol Appl Pharmacol       Date:  2009-05-03       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.